SOBRE ESTE PODCAST 🔗
How do we transform cutting-edge scientific discoveries into life-saving diagnostics?
On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx.
Learn to:
🔹 Navigate industry challenges
🔹 Understand emerging science
🔹 Strategise for growth
🔹 Gain future-focused insight
Essential listening for everyone involved in bringing new sciences to life in the Dx and Omics industry, Subscribe now!
On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx.
Learn to:
🔹 Navigate industry challenges
🔹 Understand emerging science
🔹 Strategise for growth
🔹 Gain future-focused insight
Essential listening for everyone involved in bringing new sciences to life in the Dx and Omics industry, Subscribe now!
Apresentadores:
Frequência de atualização:
weekly
Duração média do áudio:
45 minutes
Entrevistas com convidados
Inglês
Estados Unidos da América
60 episódios
desde 25 de Junho de 2025
episodic
ÚLTIMO EPISÓDIO 🔗
In this episode of Diagnosing Dx, David Filby is joined by Kavya Swaminathan, PhD, Co-Founder and CEO of Kascaid.
An immunologist and proteomics scientist by training, Kavya has spent her career studying immune dysregulation and biomarker discovery. That experience led to Kascaid and a fundamental …
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de Diagnosing Dx.
EPISÓDIOS ANTERIORES 🔗
In this episode of Diagnosing Dx, David Filby is joined by Paul Kase, Chief Commercial Officer at Lumos Diagnostics.
Paul brings 30 years of healthcare experience, including more than 20 years in rapid point-of-care diagnostics. His history with FebriDx stretches back to its earliest development, a…
In this episode of Diagnosing Dx, David Filby is joined by Marty Keiser, Founder and CEO of IVBH.
After beginning his career in asset management and capital markets, Marty moved into biotech eight years ago with a focus on blood-based molecular diagnostics and early disease detection. That outside…
In this episode of Diagnosing Dx, David Filby is joined by Raymond Tarr, Founder of Sagacity Diagnostics.
Raymond brings more than 25 years of experience across diagnostics, rare disease, commercialisation and patient finding, with previous roles spanning companies including Cepheid and AstraZeneca…
In this episode of Diagnosing Dx, David Filby is joined by Robert Carlson, Founder and President of Life Science Dx Consulting.
Robert brings 30 years of experience across diagnostics and life sciences, spanning scientific, commercial, corporate development and executive leadership roles.
He expl…
In this episode of Diagnosing Dx, David Filby is joined by Octavian Florescu, CEO of In Diagnostics.
An electrical engineer and microchip designer by training, Octavian has spent his career exploring how semiconductor technology can be applied to blood testing. After building and exiting his first…
In this episode of Diagnosing Dx, David Filby is joined by Nicole Bell, CEO of Galaxy Diagnostics.
Nicole’s route into vector-borne disease diagnostics is deeply personal. After her husband was initially diagnosed with early-onset Alzheimer’s disease, she continued searching for answers and later …
In this episode of Diagnosing Dx, David Filby is joined by Andrew Miller, a diagnostics founder, advisor and two-time exited CEO.
A scientist by training, Andrew founded and led companies focused on rapid molecular diagnostics, taking Ionian Technologies through acquisition by Alere and later buil…
In this episode of Diagnosing Dx, David Filby is joined by Travis Wold, Chief Executive Officer at Imagenomix.
Travis brings experience across cancer diagnostics, genomics, liquid biopsy, and international commercialization. We explore how Imagenomix is using AI to help make genomic testing more a…
In this episode of Diagnosing Dx, David Filby is joined by Nedal Safwat, Senior Vice President of Medical Diagnostics at Canatu and President of Canatu Inc.
With more than 20 years in diagnostics, Nedal has held leadership roles across Cepheid, QIAGEN, bioMérieux and Luminex. He now leads Canatu’s…
Aviso: O podcast e a arte incorporada nesta página são de Elevra Consulting, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
MOTOR DE PESQUISA DE PODCAST
Pode usar nosso site para pesquisar podcasts3,824,057e episódios195,727,991por pessoas, lugares ou tópicos.
Investir em conhecimento rende os melhores juros; por isso, ouço podcasts.
‐ Benjamin "Llamacorn" Franklin
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de Diagnosing Dx.
RECLAMAR ESTE PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post anúncios classificados for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
entrevista com podcaster...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
a nossa conta oficial no X (anteriormente Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.
